| 2.0 |
8.0 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.7 |
5.2 |
GO:0050894 |
determination of affect(GO:0050894) |
| 1.0 |
3.0 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 1.0 |
3.0 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 1.0 |
1.0 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.8 |
2.5 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.8 |
0.8 |
GO:0031076 |
embryonic camera-type eye development(GO:0031076) |
| 0.8 |
4.7 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.7 |
2.9 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.7 |
2.2 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.7 |
2.1 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.6 |
1.9 |
GO:0070429 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.6 |
3.8 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.6 |
0.6 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.6 |
0.6 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.6 |
1.8 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.6 |
2.4 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.6 |
1.7 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.5 |
0.5 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.5 |
0.5 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.5 |
0.5 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.5 |
0.5 |
GO:0035907 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.5 |
5.7 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.5 |
3.8 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 0.5 |
1.9 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.5 |
1.4 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.5 |
1.4 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.5 |
1.8 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.4 |
0.4 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.4 |
2.6 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.4 |
0.4 |
GO:0048596 |
embryonic camera-type eye morphogenesis(GO:0048596) |
| 0.4 |
1.3 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.4 |
1.3 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.4 |
1.3 |
GO:0060929 |
Purkinje myocyte differentiation(GO:0003168) septum secundum development(GO:0003285) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.4 |
2.6 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
1.7 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.4 |
1.2 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.4 |
1.2 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.4 |
2.0 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.4 |
2.0 |
GO:2000691 |
regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.4 |
3.2 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 |
2.8 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.4 |
1.2 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.4 |
2.7 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.4 |
1.1 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.4 |
7.2 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.4 |
0.4 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.4 |
1.9 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.4 |
1.1 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.4 |
1.1 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.4 |
1.1 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.4 |
1.1 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.4 |
0.7 |
GO:0072175 |
epithelial tube formation(GO:0072175) |
| 0.4 |
3.6 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.4 |
2.1 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.4 |
2.5 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.4 |
0.7 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.4 |
1.1 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.4 |
1.4 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.4 |
0.4 |
GO:0007292 |
female gamete generation(GO:0007292) |
| 0.3 |
1.0 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.3 |
2.1 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 |
0.7 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.3 |
2.7 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.3 |
0.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.3 |
2.7 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.3 |
1.0 |
GO:2000625 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.3 |
1.0 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 |
0.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 |
0.3 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.3 |
1.0 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.3 |
1.6 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.3 |
0.6 |
GO:0090330 |
regulation of platelet aggregation(GO:0090330) |
| 0.3 |
1.2 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.3 |
7.0 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.3 |
1.2 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.3 |
0.6 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.3 |
3.3 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 |
2.4 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.3 |
1.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.3 |
0.9 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.3 |
1.5 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 |
1.2 |
GO:0061349 |
cardiac right atrium morphogenesis(GO:0003213) chemoattraction of serotonergic neuron axon(GO:0036517) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.3 |
2.0 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 |
1.1 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.3 |
1.1 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.3 |
1.1 |
GO:0061324 |
glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.3 |
0.8 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.3 |
3.0 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.3 |
5.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.3 |
0.3 |
GO:0014870 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) |
| 0.3 |
5.1 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
0.3 |
GO:0046545 |
development of primary female sexual characteristics(GO:0046545) female sex differentiation(GO:0046660) |
| 0.3 |
0.5 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.3 |
1.9 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.3 |
2.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.3 |
0.3 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.3 |
0.8 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.3 |
2.1 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 |
0.8 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.3 |
2.3 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 |
0.3 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.3 |
1.5 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 |
2.0 |
GO:0060073 |
micturition(GO:0060073) smooth muscle contraction involved in micturition(GO:0060083) |
| 0.3 |
1.8 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.3 |
2.5 |
GO:0046078 |
pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.3 |
0.3 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.3 |
0.8 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.3 |
0.5 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.3 |
0.8 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.2 |
0.5 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.2 |
0.7 |
GO:1990869 |
response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.2 |
0.5 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 |
1.0 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.2 |
0.7 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
1.7 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 |
1.0 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.2 |
1.0 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
2.7 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.2 |
2.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.2 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.2 |
1.4 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
2.4 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.2 |
0.9 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.2 |
1.7 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
0.7 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.2 |
0.9 |
GO:0050993 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.2 |
0.2 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.2 |
1.9 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
0.2 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 |
0.2 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.2 |
0.7 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 |
1.6 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.2 |
2.3 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 |
0.9 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.2 |
1.6 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 |
0.9 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 |
0.5 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.2 |
2.3 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 |
0.9 |
GO:0052214 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.2 |
0.4 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.2 |
0.9 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.2 |
1.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
0.2 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.2 |
3.3 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.2 |
1.3 |
GO:0042560 |
folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
0.2 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.2 |
0.6 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.2 |
1.1 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 |
0.2 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.2 |
0.2 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) |
| 0.2 |
0.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.6 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 |
1.1 |
GO:0050668 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.2 |
0.9 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.2 |
2.8 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.2 |
0.6 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 0.2 |
0.9 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 0.2 |
1.1 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.2 |
0.4 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.2 |
0.6 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.2 |
1.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 |
0.4 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.2 |
0.4 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
7.3 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
1.5 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
2.7 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
0.6 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.2 |
0.6 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.2 |
1.7 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
0.8 |
GO:1904800 |
regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 |
0.6 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.2 |
0.4 |
GO:0015802 |
basic amino acid transport(GO:0015802) arginine transport(GO:0015809) arginine transmembrane transport(GO:1903826) |
| 0.2 |
0.8 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.2 |
1.4 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 |
0.4 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.2 |
0.6 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.2 |
0.4 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.2 |
1.0 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
0.4 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.2 |
0.2 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.2 |
0.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.2 |
0.2 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.2 |
2.4 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.2 |
2.4 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.2 |
5.0 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
1.4 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
1.6 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.2 |
0.6 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.2 |
1.0 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.2 |
1.0 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.2 |
0.2 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.2 |
0.8 |
GO:0003352 |
regulation of cilium movement(GO:0003352) |
| 0.2 |
0.8 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.2 |
0.2 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.2 |
0.6 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.2 |
0.2 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.2 |
3.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
1.0 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.2 |
0.6 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 |
0.4 |
GO:0060872 |
semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
| 0.2 |
1.4 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.2 |
1.9 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 |
0.6 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.2 |
3.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
3.1 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.9 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) |
| 0.2 |
0.6 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.2 |
0.6 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.2 |
1.1 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
0.8 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.2 |
0.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
0.6 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.2 |
1.1 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 |
0.7 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 |
1.5 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.2 |
2.4 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 |
1.5 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.2 |
0.7 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.2 |
0.6 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.2 |
0.6 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.2 |
0.5 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.2 |
0.7 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 |
0.5 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.2 |
0.7 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.2 |
1.3 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.2 |
0.9 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 |
2.7 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.2 |
0.2 |
GO:0060516 |
primary prostatic bud elongation(GO:0060516) |
| 0.2 |
0.5 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.2 |
1.6 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.2 |
2.5 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 |
0.2 |
GO:0003193 |
pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.2 |
0.9 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 |
0.4 |
GO:0065002 |
intracellular protein transmembrane transport(GO:0065002) |
| 0.2 |
0.2 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
1.1 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.2 |
0.5 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.2 |
0.5 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.2 |
0.7 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.2 |
0.4 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 |
0.5 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.2 |
0.5 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
0.5 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.2 |
1.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.2 |
1.1 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.2 |
1.4 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 |
0.7 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.2 |
1.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
0.3 |
GO:0045599 |
regulation of fat cell differentiation(GO:0045598) negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 |
0.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
0.5 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.2 |
0.7 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.2 |
1.6 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.2 |
2.3 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.2 |
0.7 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.2 |
2.2 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 |
2.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
1.2 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.2 |
2.7 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.2 |
0.5 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.2 |
0.2 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
0.7 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 |
0.2 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.2 |
0.5 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.2 |
0.5 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
0.7 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
0.5 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.2 |
0.5 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.2 |
0.5 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.2 |
1.7 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 |
0.2 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.2 |
3.0 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.2 |
0.5 |
GO:1902910 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.2 |
1.5 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 |
0.5 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.2 |
1.0 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.2 |
4.9 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
0.2 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 |
0.8 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.2 |
0.7 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
0.7 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.2 |
4.1 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 |
1.0 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.2 |
1.0 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 |
0.5 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.2 |
1.8 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
0.3 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.2 |
0.8 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 |
0.2 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.2 |
0.8 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 |
0.6 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.2 |
0.5 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.2 |
1.6 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 |
0.6 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 |
1.0 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 |
0.6 |
GO:0044053 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.2 |
2.4 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
1.6 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
3.2 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
0.3 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.2 |
0.6 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 |
0.6 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
0.2 |
GO:0019401 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.2 |
0.8 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 |
0.5 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.2 |
0.2 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.2 |
1.4 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.2 |
0.5 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.2 |
0.5 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.2 |
0.2 |
GO:0021769 |
orbitofrontal cortex development(GO:0021769) |
| 0.2 |
0.6 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.2 |
0.2 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.2 |
1.3 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.2 |
0.3 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.2 |
0.2 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.2 |
0.9 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.2 |
1.4 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.2 |
0.5 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.2 |
0.8 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 |
0.6 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 |
1.1 |
GO:0070383 |
DNA cytosine deamination(GO:0070383) |
| 0.2 |
0.5 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.2 |
0.5 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.2 |
0.5 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.2 |
0.5 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.2 |
0.3 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
0.8 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.2 |
0.3 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 |
0.3 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.2 |
0.6 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.2 |
0.9 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 |
2.6 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 |
0.6 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
1.6 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.1 |
0.4 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 |
0.4 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.1 |
0.1 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 |
0.4 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.1 |
0.6 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
1.2 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.3 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) |
| 0.1 |
0.6 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.1 |
0.9 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.1 |
0.4 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.1 |
0.1 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 |
1.5 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
1.6 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.1 |
0.7 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.1 |
2.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.3 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
1.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.6 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.4 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.1 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.1 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.1 |
0.6 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.1 |
0.7 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.1 |
0.4 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 |
0.4 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.7 |
GO:0009183 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.1 |
0.4 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.1 |
2.9 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.6 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 |
0.1 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.1 |
0.1 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.1 |
0.4 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
8.0 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 |
0.3 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.1 |
0.5 |
GO:0070091 |
glucagon secretion(GO:0070091) |
| 0.1 |
0.4 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.1 |
1.9 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
0.3 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.7 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
2.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
1.1 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 |
0.9 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
2.3 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.1 |
GO:0006760 |
folic acid-containing compound metabolic process(GO:0006760) pteridine-containing compound metabolic process(GO:0042558) |
| 0.1 |
0.1 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
0.4 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.1 |
0.4 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 |
4.0 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
0.4 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.1 |
1.5 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
0.5 |
GO:1903859 |
regulation of dendrite extension(GO:1903859) |
| 0.1 |
0.3 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 |
0.3 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.5 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
2.8 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
2.2 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
0.7 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.8 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.1 |
2.3 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 |
1.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.5 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.1 |
0.6 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.6 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.6 |
GO:0035264 |
multicellular organism growth(GO:0035264) |
| 0.1 |
0.8 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.8 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
0.3 |
GO:0070103 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
| 0.1 |
0.1 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.1 |
0.4 |
GO:0010469 |
regulation of receptor activity(GO:0010469) |
| 0.1 |
0.4 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.1 |
0.6 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 |
0.1 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
0.3 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.1 |
0.1 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.4 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.3 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.3 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.1 |
0.5 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.1 |
0.1 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.1 |
0.1 |
GO:0036302 |
atrioventricular canal development(GO:0036302) |
| 0.1 |
0.5 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.1 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
0.6 |
GO:0071874 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 |
0.5 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.1 |
0.8 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 |
1.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.2 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.1 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.1 |
2.3 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.1 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.1 |
0.2 |
GO:0098779 |
mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.1 |
0.4 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.1 |
0.9 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.1 |
0.6 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 |
0.6 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
1.0 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.2 |
GO:0043385 |
mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.1 |
0.2 |
GO:0003382 |
epithelial cell morphogenesis(GO:0003382) |
| 0.1 |
3.9 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.7 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.5 |
GO:1902661 |
positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.1 |
1.4 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.1 |
GO:1904181 |
positive regulation of membrane depolarization(GO:1904181) |
| 0.1 |
0.1 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.1 |
0.2 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
2.6 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
1.3 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.1 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.1 |
0.1 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
0.6 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.4 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.1 |
0.5 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.1 |
0.7 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.1 |
0.6 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 |
0.4 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 |
2.1 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.4 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.1 |
0.5 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.1 |
0.2 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.1 |
0.1 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.1 |
0.5 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.1 |
1.6 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
0.2 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 |
0.3 |
GO:0070376 |
regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.1 |
0.5 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.8 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
1.9 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 |
0.3 |
GO:0044829 |
modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
1.0 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
2.1 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.1 |
GO:0034312 |
diol biosynthetic process(GO:0034312) polyol biosynthetic process(GO:0046173) sphingosine biosynthetic process(GO:0046512) |
| 0.1 |
0.2 |
GO:0019860 |
uracil metabolic process(GO:0019860) |
| 0.1 |
0.5 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.1 |
1.0 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 |
4.6 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.1 |
0.3 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
0.5 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.7 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.2 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.3 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.3 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.1 |
0.1 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.1 |
0.7 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.1 |
GO:0015820 |
leucine transport(GO:0015820) |
| 0.1 |
0.4 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 |
0.4 |
GO:0070528 |
protein kinase C signaling(GO:0070528) |
| 0.1 |
0.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
1.6 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 |
0.2 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 |
0.3 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
1.0 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.3 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.1 |
1.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.2 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
0.5 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
1.2 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 |
0.4 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.4 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.1 |
0.5 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.1 |
0.2 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.1 |
0.7 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.3 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.1 |
0.1 |
GO:0044597 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.1 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
0.6 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.8 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.4 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 |
0.3 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.1 |
0.2 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 |
0.3 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
0.1 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
0.4 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.2 |
GO:0072229 |
proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 0.1 |
0.1 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.3 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
0.6 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.1 |
0.3 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.1 |
0.3 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
0.7 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
1.4 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.3 |
GO:1904235 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.1 |
0.2 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 |
0.5 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 |
1.5 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.1 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.1 |
1.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.3 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.1 |
0.5 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.1 |
0.5 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 |
0.5 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 |
0.3 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 |
0.5 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.1 |
1.2 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.1 |
0.4 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 |
0.6 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
0.3 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.1 |
0.3 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.1 |
1.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.1 |
GO:0061136 |
regulation of proteasomal protein catabolic process(GO:0061136) |
| 0.1 |
0.5 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.2 |
GO:0070859 |
lipid transport involved in lipid storage(GO:0010877) positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.1 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.4 |
GO:0045872 |
regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.3 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.7 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.1 |
0.9 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 |
1.5 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
3.7 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.1 |
0.7 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
1.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.4 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 |
0.8 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
0.2 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
1.3 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.3 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
1.1 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.6 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.1 |
0.5 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.1 |
0.2 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 |
0.9 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 |
0.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.7 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.1 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.1 |
0.8 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
0.8 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.8 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.8 |
GO:1903333 |
negative regulation of protein folding(GO:1903333) |
| 0.1 |
0.1 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
0.2 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.8 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
1.4 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.1 |
0.4 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 |
0.3 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 |
0.2 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.1 |
0.5 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.1 |
0.1 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 |
0.5 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 |
0.5 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.1 |
GO:0042398 |
cellular modified amino acid biosynthetic process(GO:0042398) |
| 0.1 |
0.1 |
GO:1902176 |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.1 |
1.7 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.4 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.1 |
0.6 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.5 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 |
0.6 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.3 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.1 |
0.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.1 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.1 |
0.8 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.6 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.1 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.1 |
0.2 |
GO:0009074 |
aromatic amino acid family catabolic process(GO:0009074) |
| 0.1 |
0.6 |
GO:0014733 |
regulation of skeletal muscle adaptation(GO:0014733) |
| 0.1 |
0.2 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.9 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
1.5 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 |
0.4 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.2 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.3 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.1 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.2 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 |
0.2 |
GO:0002568 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.1 |
0.3 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
0.7 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.5 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.1 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.1 |
2.3 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.1 |
2.8 |
GO:0006677 |
glycosylceramide metabolic process(GO:0006677) |
| 0.1 |
0.2 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
2.5 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.6 |
GO:2000782 |
regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.1 |
0.2 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.1 |
0.4 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 |
0.1 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.1 |
0.2 |
GO:0071262 |
positive regulation of translational initiation in response to stress(GO:0032058) regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.1 |
0.3 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.1 |
0.4 |
GO:0030858 |
positive regulation of epithelial cell differentiation(GO:0030858) |
| 0.1 |
0.7 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
0.6 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
1.0 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.1 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 0.1 |
0.3 |
GO:1902750 |
negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.1 |
0.3 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.2 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.1 |
0.2 |
GO:0043397 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.1 |
1.4 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.1 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.3 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.4 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.3 |
GO:0009407 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.1 |
0.1 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
| 0.1 |
0.2 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.1 |
0.2 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 |
0.2 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.1 |
0.3 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.1 |
0.2 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
0.2 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.1 |
0.7 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.1 |
0.2 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 |
0.5 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
0.2 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.1 |
0.5 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 |
0.2 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.1 |
0.5 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 |
0.3 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.1 |
0.1 |
GO:0006293 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.1 |
0.8 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.3 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.1 |
0.2 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 |
0.4 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.1 |
0.3 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.3 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 |
0.9 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.2 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 |
0.7 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.1 |
GO:0046174 |
polyol catabolic process(GO:0046174) |
| 0.1 |
0.2 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.7 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
1.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.5 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.1 |
0.2 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.1 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
1.5 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
0.5 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
0.2 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.3 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.1 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.3 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
1.0 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
| 0.1 |
0.2 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.1 |
0.8 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.2 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.1 |
0.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.2 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.1 |
0.2 |
GO:0032196 |
transposition(GO:0032196) |
| 0.1 |
1.0 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.2 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.1 |
0.4 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.3 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 |
0.4 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.2 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 |
0.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.4 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.1 |
2.8 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 |
0.6 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
1.3 |
GO:0009755 |
hormone-mediated signaling pathway(GO:0009755) |
| 0.1 |
0.3 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.3 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
0.1 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 |
0.2 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.1 |
0.5 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 |
0.2 |
GO:0043970 |
histone H3-K9 acetylation(GO:0043970) |
| 0.1 |
0.1 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.4 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 |
0.6 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.1 |
0.5 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
1.4 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.2 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.1 |
0.2 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.2 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 |
0.5 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.1 |
GO:0045934 |
negative regulation of nucleobase-containing compound metabolic process(GO:0045934) |
| 0.1 |
0.1 |
GO:0050976 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.1 |
0.1 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.4 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.4 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.1 |
GO:1901983 |
regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) regulation of peptidyl-lysine acetylation(GO:2000756) |
| 0.1 |
0.4 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.4 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
0.4 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.1 |
0.1 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 |
3.4 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 |
0.7 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.1 |
0.6 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.4 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
0.3 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.1 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
| 0.1 |
0.3 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.1 |
0.1 |
GO:0071283 |
cellular response to iron(III) ion(GO:0071283) |
| 0.1 |
0.1 |
GO:0070423 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.1 |
0.3 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.1 |
0.3 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.2 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.1 |
0.2 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.1 |
0.1 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.1 |
0.9 |
GO:0006281 |
DNA repair(GO:0006281) |
| 0.1 |
0.1 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.1 |
0.1 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.1 |
0.7 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 |
0.3 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
1.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.1 |
GO:0055008 |
muscle organ morphogenesis(GO:0048644) cardiac muscle tissue morphogenesis(GO:0055008) |
| 0.1 |
0.3 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.1 |
0.1 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
0.2 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 |
0.1 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 |
0.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.4 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.2 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 |
0.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.4 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
9.6 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.1 |
0.4 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.1 |
0.6 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.1 |
GO:0070142 |
synaptic vesicle budding(GO:0070142) |
| 0.1 |
0.4 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
1.1 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.6 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
0.3 |
GO:0061205 |
alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
| 0.1 |
0.1 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.1 |
1.4 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.2 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.1 |
0.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
3.4 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.3 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
0.2 |
GO:1901340 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.1 |
0.1 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.1 |
0.9 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.1 |
GO:0014831 |
intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.1 |
1.5 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.1 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 |
0.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
2.5 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.1 |
0.1 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.1 |
0.5 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 |
0.1 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) |
| 0.1 |
0.4 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.1 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.4 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
0.1 |
GO:0071599 |
otic vesicle development(GO:0071599) |
| 0.1 |
0.9 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.1 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
1.2 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.1 |
GO:0060921 |
sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) |
| 0.1 |
0.1 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 |
0.7 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
1.3 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
3.4 |
GO:1903307 |
positive regulation of regulated secretory pathway(GO:1903307) |
| 0.1 |
0.1 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 |
0.2 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.3 |
GO:0009886 |
post-embryonic morphogenesis(GO:0009886) post-embryonic organ morphogenesis(GO:0048563) |
| 0.1 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.1 |
GO:0003164 |
His-Purkinje system development(GO:0003164) Purkinje myocyte development(GO:0003165) |
| 0.1 |
0.7 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
0.8 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.3 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.3 |
GO:0035947 |
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.1 |
0.3 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.7 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 |
2.6 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 |
1.3 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.1 |
0.1 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.1 |
0.3 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.6 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.1 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.1 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.1 |
1.4 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
0.2 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.2 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.1 |
0.3 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.6 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.2 |
GO:0048865 |
stem cell fate commitment(GO:0048865) |
| 0.1 |
0.1 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 |
0.4 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.1 |
0.2 |
GO:0002545 |
microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.1 |
0.6 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.4 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
2.5 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
1.6 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.5 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
1.7 |
GO:0071402 |
cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.1 |
0.7 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.1 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.1 |
0.7 |
GO:0010310 |
regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.1 |
0.2 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.1 |
3.4 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.1 |
0.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
0.1 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.1 |
1.7 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.1 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.1 |
0.1 |
GO:0050807 |
regulation of synapse organization(GO:0050807) |
| 0.1 |
0.9 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
0.4 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.1 |
0.4 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 |
0.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.3 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.1 |
0.5 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 |
0.2 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.1 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.4 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.7 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 |
0.2 |
GO:2000229 |
regulation of cholesterol transporter activity(GO:0060694) cellular response to vitamin E(GO:0071306) pancreatic stellate cell proliferation(GO:0072343) response to metformin(GO:1901558) regulation of pancreatic stellate cell proliferation(GO:2000229) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.1 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.1 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 |
0.8 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.1 |
1.8 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.1 |
0.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
2.7 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.1 |
4.1 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
0.2 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.1 |
GO:0045073 |
regulation of chemokine biosynthetic process(GO:0045073) |
| 0.1 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
1.0 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.2 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.1 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.1 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.1 |
1.4 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
2.4 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
0.2 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 |
0.1 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) |
| 0.1 |
0.1 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.1 |
0.2 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.1 |
0.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 |
0.1 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.1 |
0.1 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.1 |
0.3 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 |
2.2 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.1 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.1 |
0.3 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.1 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.1 |
1.1 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
0.2 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 |
0.1 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.1 |
0.2 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.3 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.1 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.2 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 |
0.2 |
GO:0006147 |
guanine catabolic process(GO:0006147) |
| 0.1 |
0.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.1 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.1 |
0.4 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.1 |
0.2 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
0.2 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.6 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.6 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.2 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.1 |
0.1 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.1 |
0.6 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
1.5 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.1 |
0.2 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.4 |
GO:1904874 |
positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.1 |
0.2 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.2 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
0.1 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.1 |
0.1 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
0.3 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
2.1 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.1 |
0.4 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.1 |
0.2 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.3 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.1 |
1.7 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.1 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.1 |
0.2 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.1 |
0.9 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.4 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
0.1 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.1 |
0.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.6 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.1 |
0.2 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.1 |
0.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.3 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 |
0.2 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.1 |
0.8 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.2 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.1 |
0.2 |
GO:0021831 |
embryonic olfactory bulb interneuron precursor migration(GO:0021831) chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
| 0.1 |
1.1 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
0.2 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.1 |
0.1 |
GO:0061356 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
| 0.1 |
0.3 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.1 |
0.9 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.1 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.3 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.2 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
0.2 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
1.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
1.2 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.1 |
1.4 |
GO:0061718 |
NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 |
0.2 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.1 |
0.2 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 |
0.2 |
GO:0061037 |
negative regulation of cartilage development(GO:0061037) |
| 0.1 |
0.7 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
0.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.5 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.2 |
GO:0031333 |
negative regulation of protein complex assembly(GO:0031333) |
| 0.1 |
0.2 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 |
0.1 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
2.5 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.3 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
0.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.5 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.0 |
0.1 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.1 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.0 |
0.5 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.3 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.0 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.1 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.0 |
1.2 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.0 |
GO:0051664 |
nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
| 0.0 |
0.4 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.0 |
0.2 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.3 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.1 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.0 |
0.7 |
GO:0090083 |
inclusion body assembly(GO:0070841) regulation of inclusion body assembly(GO:0090083) |
| 0.0 |
0.4 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.0 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.3 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.0 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.2 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 |
0.3 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.3 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.0 |
0.1 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.2 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
0.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.1 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.0 |
0.1 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.0 |
0.2 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.0 |
0.3 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.1 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.0 |
0.6 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.0 |
0.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.5 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.0 |
0.3 |
GO:0015942 |
formate metabolic process(GO:0015942) |
| 0.0 |
1.5 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.3 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.7 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.3 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.0 |
4.7 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.0 |
GO:0036491 |
regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.0 |
0.3 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.0 |
1.3 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
0.0 |
GO:1900111 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.0 |
0.2 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.1 |
GO:0046495 |
purine ribonucleoside salvage(GO:0006166) nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.0 |
0.2 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 0.0 |
0.3 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 |
0.3 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.0 |
0.1 |
GO:1903978 |
regulation of microglial cell activation(GO:1903978) |
| 0.0 |
0.3 |
GO:0035412 |
regulation of catenin import into nucleus(GO:0035412) |
| 0.0 |
0.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.3 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.0 |
0.1 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.0 |
0.2 |
GO:0032648 |
regulation of interferon-beta production(GO:0032648) |
| 0.0 |
0.1 |
GO:0032930 |
positive regulation of superoxide anion generation(GO:0032930) |
| 0.0 |
0.0 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.0 |
0.5 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.0 |
0.1 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.0 |
0.1 |
GO:0002476 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.0 |
0.3 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.5 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.0 |
0.9 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
2.2 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.0 |
GO:1902884 |
positive regulation of response to oxidative stress(GO:1902884) |
| 0.0 |
0.0 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.0 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.0 |
0.0 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.0 |
0.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.0 |
0.0 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.0 |
0.7 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.3 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.0 |
0.1 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.0 |
0.2 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.0 |
0.1 |
GO:0006302 |
double-strand break repair(GO:0006302) |
| 0.0 |
0.0 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.5 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.0 |
0.5 |
GO:0048505 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.0 |
0.1 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.0 |
0.2 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.0 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.0 |
0.0 |
GO:0010883 |
regulation of lipid storage(GO:0010883) |
| 0.0 |
0.7 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.1 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.0 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.7 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.0 |
0.0 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.0 |
0.0 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.0 |
1.0 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.2 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.0 |
0.1 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.0 |
0.1 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
0.0 |
GO:0003230 |
cardiac atrium development(GO:0003230) |
| 0.0 |
0.3 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.0 |
0.4 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.0 |
2.1 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.1 |
GO:0060381 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.0 |
0.3 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 |
0.1 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.0 |
0.2 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.1 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.2 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.0 |
0.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.6 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.1 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.0 |
0.5 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.2 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.3 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.4 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 |
0.5 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.2 |
GO:0035087 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.0 |
0.2 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) |
| 0.0 |
0.9 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.3 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.0 |
0.0 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.9 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.2 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.1 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 0.0 |
0.2 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.0 |
0.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.4 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.1 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.0 |
0.0 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.0 |
0.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.1 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.0 |
1.2 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.4 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.2 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.0 |
0.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.0 |
0.0 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 |
0.2 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.0 |
0.0 |
GO:1902567 |
negative regulation of eosinophil activation(GO:1902567) |
| 0.0 |
0.0 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.0 |
1.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.3 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.1 |
GO:0042747 |
circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.0 |
0.0 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.0 |
1.3 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.0 |
GO:0042471 |
ear morphogenesis(GO:0042471) |
| 0.0 |
0.3 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.2 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:0048073 |
eye pigmentation(GO:0048069) regulation of eye pigmentation(GO:0048073) |
| 0.0 |
0.9 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.0 |
0.2 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
0.4 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.6 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.3 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.0 |
0.5 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.0 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.0 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.0 |
0.0 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.0 |
4.8 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.0 |
0.0 |
GO:0071373 |
cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.0 |
0.1 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.1 |
GO:0032431 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of phospholipase A2 activity(GO:0032431) |
| 0.0 |
0.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 |
0.1 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.0 |
0.6 |
GO:0018210 |
peptidyl-threonine modification(GO:0018210) |
| 0.0 |
0.2 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.1 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.0 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.0 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 |
0.3 |
GO:0071415 |
cellular response to purine-containing compound(GO:0071415) |
| 0.0 |
4.3 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.1 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.0 |
0.1 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
1.6 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
0.0 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.0 |
0.0 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.1 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 0.0 |
0.2 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
2.1 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.0 |
0.5 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.4 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 |
0.1 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.3 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.4 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.3 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
| 0.0 |
0.1 |
GO:0060532 |
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.0 |
0.1 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.0 |
0.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.2 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.0 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
0.3 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.0 |
0.0 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 |
0.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.4 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.0 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.0 |
0.1 |
GO:0018194 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.0 |
0.0 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.1 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.1 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.2 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
1.4 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.3 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.0 |
0.1 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 0.0 |
0.2 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.0 |
0.1 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.0 |
0.8 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.0 |
0.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.7 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.3 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.2 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.1 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.3 |
GO:0070664 |
negative regulation of leukocyte proliferation(GO:0070664) |
| 0.0 |
0.4 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.3 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.0 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.1 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.0 |
0.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.4 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.2 |
GO:0046148 |
pigment biosynthetic process(GO:0046148) |
| 0.0 |
0.2 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.0 |
0.4 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) |
| 0.0 |
0.3 |
GO:2000641 |
regulation of early endosome to late endosome transport(GO:2000641) |
| 0.0 |
1.5 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.1 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.0 |
0.1 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 |
0.1 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.8 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.3 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.0 |
0.0 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.0 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.0 |
0.7 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.1 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.0 |
0.2 |
GO:0031346 |
positive regulation of cell projection organization(GO:0031346) |
| 0.0 |
0.2 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.9 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.0 |
0.4 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.1 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.0 |
0.2 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.0 |
0.1 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.0 |
0.0 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.0 |
0.1 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.0 |
0.3 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.0 |
0.1 |
GO:0031670 |
cellular response to nutrient(GO:0031670) |
| 0.0 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
2.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.2 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
2.8 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.5 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.1 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.0 |
0.2 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.0 |
0.7 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.7 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.2 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.0 |
0.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
1.5 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.1 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.0 |
GO:0060896 |
neural plate pattern specification(GO:0060896) |
| 0.0 |
0.1 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.1 |
GO:2000620 |
regulation of histone H4-K16 acetylation(GO:2000618) positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.0 |
0.6 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.0 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.0 |
0.0 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
0.2 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.0 |
0.2 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.0 |
1.3 |
GO:0016071 |
mRNA metabolic process(GO:0016071) |
| 0.0 |
0.7 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.0 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
0.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.4 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 |
0.8 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.1 |
GO:0014888 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) striated muscle adaptation(GO:0014888) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.2 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.4 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.1 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.0 |
0.1 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.3 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.1 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.0 |
0.1 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.0 |
0.0 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.0 |
0.0 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:0045661 |
regulation of myoblast differentiation(GO:0045661) |
| 0.0 |
0.0 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.2 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.1 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.0 |
0.4 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.1 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) regulation of rRNA processing(GO:2000232) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
1.8 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.1 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.0 |
0.0 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.0 |
0.4 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.2 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.0 |
0.1 |
GO:1905225 |
response to thyrotropin-releasing hormone(GO:1905225) |
| 0.0 |
0.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.0 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.0 |
1.4 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.1 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.0 |
0.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.2 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.0 |
0.6 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.0 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.0 |
0.2 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.0 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.0 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.0 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.0 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.1 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.0 |
0.2 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.0 |
0.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.0 |
0.1 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.0 |
0.3 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.1 |
GO:0016260 |
selenocysteine metabolic process(GO:0016259) selenocysteine biosynthetic process(GO:0016260) |
| 0.0 |
0.4 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.2 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.0 |
0.1 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.0 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.0 |
0.1 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.0 |
0.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.1 |
GO:2000364 |
central nervous system morphogenesis(GO:0021551) cardiac muscle tissue regeneration(GO:0061026) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.0 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.0 |
0.0 |
GO:1902869 |
amacrine cell differentiation(GO:0035881) regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) regulation of amacrine cell differentiation(GO:1902869) |
| 0.0 |
0.1 |
GO:0045209 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.0 |
1.0 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.3 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.1 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.0 |
0.1 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.1 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.1 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.0 |
0.1 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.0 |
1.9 |
GO:0051439 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.0 |
0.1 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.0 |
0.2 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.0 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.0 |
0.0 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.0 |
0.1 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.1 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) |
| 0.0 |
0.2 |
GO:0060119 |
inner ear receptor cell development(GO:0060119) |
| 0.0 |
0.0 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.0 |
0.1 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.1 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.0 |
0.3 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.1 |
GO:0060768 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.0 |
0.0 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.0 |
GO:0019856 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.0 |
0.2 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.4 |
GO:1902593 |
single-organism nuclear import(GO:1902593) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.0 |
GO:0039656 |
modulation by virus of host gene expression(GO:0039656) |
| 0.0 |
0.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.0 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.0 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.0 |
0.0 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.0 |
0.2 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.0 |
0.1 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.0 |
0.0 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 0.0 |
0.4 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.1 |
GO:0044786 |
cell cycle DNA replication(GO:0044786) |
| 0.0 |
0.2 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.0 |
0.1 |
GO:1901623 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.0 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.2 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.2 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 |
0.1 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.0 |
0.0 |
GO:0050755 |
chemokine metabolic process(GO:0050755) |
| 0.0 |
0.2 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.0 |
0.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.1 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
0.1 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
0.9 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.1 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 |
0.5 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.2 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.0 |
0.1 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.1 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.0 |
0.0 |
GO:1902592 |
viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.0 |
0.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.0 |
0.0 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.1 |
GO:0045841 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) |
| 0.0 |
0.2 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.1 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.0 |
0.1 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.0 |
0.4 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.0 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.0 |
0.7 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 |
0.0 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.0 |
0.1 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
2.5 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 |
0.4 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
0.4 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.1 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.2 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.0 |
0.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.0 |
0.0 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.0 |
0.0 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.3 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
0.1 |
GO:0010133 |
proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) 4-hydroxyproline catabolic process(GO:0019470) |
| 0.0 |
0.1 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.1 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.0 |
0.1 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 |
0.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.2 |
GO:2000828 |
regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 |
0.1 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.0 |
0.0 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.1 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.0 |
0.0 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 |
0.1 |
GO:0019585 |
uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
| 0.0 |
0.1 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.0 |
0.1 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
1.0 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.1 |
GO:0030878 |
thyroid gland development(GO:0030878) |
| 0.0 |
0.1 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.1 |
GO:1901298 |
regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
| 0.0 |
0.1 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.0 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
1.7 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.1 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.3 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.0 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.0 |
0.0 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.0 |
0.1 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.0 |
0.2 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.1 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 |
0.0 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.0 |
0.1 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.1 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.0 |
0.0 |
GO:0002774 |
Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.0 |
0.0 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.0 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.0 |
0.1 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.0 |
0.0 |
GO:0051852 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.0 |
0.0 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.4 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.0 |
0.0 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 |
0.0 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.0 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.3 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
0.0 |
GO:0002260 |
lymphocyte homeostasis(GO:0002260) |
| 0.0 |
0.1 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.0 |
0.0 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.0 |
0.0 |
GO:0048769 |
sarcomerogenesis(GO:0048769) |
| 0.0 |
0.3 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.0 |
0.1 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.2 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
0.2 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.1 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.0 |
0.0 |
GO:0051445 |
regulation of meiotic cell cycle(GO:0051445) |
| 0.0 |
0.1 |
GO:0010737 |
protein kinase A signaling(GO:0010737) regulation of protein kinase A signaling(GO:0010738) |
| 0.0 |
0.1 |
GO:1901889 |
negative regulation of cell junction assembly(GO:1901889) |
| 0.0 |
0.1 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
0.0 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.3 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.0 |
GO:0010998 |
regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
| 0.0 |
0.1 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.1 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.0 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.0 |
0.1 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.0 |
0.1 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.0 |
1.4 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.0 |
GO:0032594 |
protein transport within lipid bilayer(GO:0032594) |
| 0.0 |
0.0 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.0 |
0.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.1 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.0 |
GO:0046368 |
GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
| 0.0 |
0.0 |
GO:0070141 |
response to UV-A(GO:0070141) cellular response to UV-A(GO:0071492) |
| 0.0 |
0.0 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.0 |
0.0 |
GO:0003188 |
heart valve formation(GO:0003188) |
| 0.0 |
0.1 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.0 |
0.1 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 |
0.1 |
GO:0043247 |
telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 |
0.0 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 |
0.1 |
GO:0044036 |
cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.0 |
0.0 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.0 |
0.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
1.0 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.0 |
0.0 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 |
0.1 |
GO:0072538 |
T-helper 17 type immune response(GO:0072538) |
| 0.0 |
0.0 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.0 |
GO:0001207 |
histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.0 |
0.1 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.0 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.0 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.0 |
0.0 |
GO:0090220 |
chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.0 |
0.0 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.0 |
0.0 |
GO:0097300 |
necrotic cell death(GO:0070265) programmed necrotic cell death(GO:0097300) |
| 0.0 |
0.1 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.0 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.0 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.0 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.0 |
0.0 |
GO:0051168 |
nuclear export(GO:0051168) |
| 0.0 |
0.0 |
GO:0015980 |
energy derivation by oxidation of organic compounds(GO:0015980) |
| 0.0 |
0.0 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
